A Post-marketing Surveillance to Assess Safety and Efficacy of Twotopsplus.

IlDong Pharmaceutical

Status: Unknown

Conditions: Hypertension

Study type: Observational

Funder types: Industry

Identifiers

NCT03655288

ID-TTP-401

Details and patient eligibility

About

Post-marketing surveillance of Twotopsplus.

Full description

This study will collect clinical data, mainly focused on safety, in Korean population as per the requirement of MFDS for market authorization.

Enrollment: 600 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• The patient diagnosed with hypertension.
• The patient who is first prescribed and administered Twotopsplus Tab.

Exclusion criteria

• The patients who are overreacting to this drug or its components.
• The patients with severe renal impairment.